Your browser doesn't support javascript.
loading
[When to consider type I interferonopathy in adulthood?] / Quand penser à une interféronopathie de type I chez l'adulte ?
David, C; Frémond, M-L.
Affiliation
  • David C; Université de Paris, Institut Imagine, laboratoire de neurogénétique et neuroinflammation, 24, boulevard du Montparnasse, 75015 Paris, France.
  • Frémond ML; Université de Paris, Institut Imagine, laboratoire de neurogénétique et neuroinflammation, 24, boulevard du Montparnasse, 75015 Paris, France; Unité d'immuno-hématologie et rhumatologie pédiatriques, centre de référence des maladies rhumatologiques et auto-immunes systémiques rares en pédiatrie (RAISE), hôpital Necker-Enfants-Malades, Centre - Université de Paris, AP-HP, 75015 Paris, France. Electronic address: marie-louise.fremond@aphp.fr.
Rev Med Interne ; 43(6): 347-355, 2022 Jun.
Article in Fr | MEDLINE | ID: mdl-35177256
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Calcinosis / Interferon Type I Limits: Adult / Humans Language: Fr Journal: Rev Med Interne Year: 2022 Document type: Article Affiliation country: France Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Calcinosis / Interferon Type I Limits: Adult / Humans Language: Fr Journal: Rev Med Interne Year: 2022 Document type: Article Affiliation country: France Country of publication: France